An Automated Alternative to Traditional NAT Methods
Автор: bioMérieux
Загружено: 2025-11-24
Просмотров: 192
The standard test for mycoplasma contamination is evolving. As macromolecule drugs derived from mammalian cells become more commonplace, reducing the turnaround time for testing and investigation on the large-scale bioreactors of today has become an indispensable need for manufacturers to ensure productivity and cost competency. Learn more about how Amgen will boost productivity, by adopting the Next Generation Nucleic Acid Amplification Test (NAT), with Chakameh Azimpour, Amgen Principal Scientist and our own Jeremy Robertson, bioMérieux Global Solution Manager.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: